Biogen Inc. balance sheet
At the end of its fiscal year on Dec 31, 2025, Biogen Inc. reported total assets of $29.44B and shareholders' equity of $18.26B. That works out to liabilities equal to 38% of assets, a current ratio of 2.68 (current assets ÷ current liabilities), long-term debt of 0.34× shareholders' equity.
Balance sheet at each fiscal year end
| Fiscal year ended | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $22.88B | $23.65B | $25.29B | $27.23B | $24.62B | $23.88B | $24.55B | $26.84B | $28.05B | $29.44B |
| Current assets | $8.73B | $7.87B | $7.64B | $8.38B | $6.89B | $7.86B | $9.79B | $6.86B | $7.46B | $8.97B |
| Cash & equivalents | $2.33B | $1.57B | $1.22B | $2.91B | $1.33B | $2.26B | $3.42B | $1.05B | $2.38B | $3.01B |
| Total liabilities | $10.75B | $11.05B | $12.26B | $13.90B | $13.93B | $12.92B | $11.17B | $12.05B | $11.33B | $11.18B |
| Current liabilities | $3.42B | $3.37B | $3.30B | $4.86B | $3.74B | $4.30B | $3.27B | $3.43B | $5.53B | $3.35B |
| Long-term debt | $6.51B | $5.93B | $5.94B | $4.46B | $7.43B | $6.27B | $6.28B | $6.94B | $6.30B | $6.29B |
| Shareholders' equity | $12.14B | $12.61B | $13.04B | $13.34B | $10.70B | $10.90B | $13.40B | $14.80B | $16.72B | $18.26B |
| Reported in | 10-K 2018 | 10-K 2019 | 10-K 2020 | 10-K 2021 | 10-K 2022 | 10-K 2023 | 10-K 2024 | 10-K 2025 | 10-K 2026 | 10-K 2026 |
Balance-sheet figures are point-in-time values on the last day of each fiscal year. Some companies (for example banks and insurers) do not present current assets and liabilities; those cells show —.
Source: SEC EDGAR XBRL company facts for CIK 875045 (raw data). Most recent filing in this dataset: 10-Q filed Oct 28, 2026. SEC data file dated Nov 3, 2026; page built Nov 5, 2026. Figures are as most recently reported, including restatements. How we select figures.